A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma
Open Access
- 12 February 2002
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 86 (4), 558-563
- https://doi.org/10.1038/sj.bjc.6600130
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Surgery in the management of small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 1997
- Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancerThe Annals of Thoracic Surgery, 1996
- P53 and angiogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Enhancement of Tumor Growth and Vascular Density by Transfection of Vascular Endothelial Cell Growth Factor Into MCF-7 Human Breast Carcinoma CellsJNCI Journal of the National Cancer Institute, 1995
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Role of Vegf-Flt Receptor System in Normal and Tumor AngiogenesisAdvances in Cancer Research, 1995
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells.JCI Insight, 1993
- Relation of neovascularisation to metastasis of non-small-cell lung cancerThe Lancet, 1992
- Novel growth regulatory factors and tumour angiogenesisEuropean Journal of Cancer and Clinical Oncology, 1991